![Sireesh Appajosyula](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sireesh Appajosyula
Vorstandsvorsitzender bei
HEPION PHARMACEUTICALS, INC.
Vermögen: 522 923 $ am 30.09.2026
Profil
Dr. Sireesh Appajosyula is a Chief Executive Officer & Director at Hepion Pharmaceuticals, Inc., a Chief Executive Officer at Gravitas Life Sciences LLC, a Managing Member at Highpoint Pharmaceuticals LLC and a Managing Partner at Channel Bioconsulting LLC.
He is on the Board of Directors at Hepion Pharmaceuticals, Inc. Dr. Appajosyula was previously employed as a Chief Financial Officer by Tharimmune, Inc., a SVP-Corporate Development & Operations by 9 Meters Biopharma, Inc., and a Head-Business Development by Salix Pharmaceuticals, Inc. He received his undergraduate degree from Rutgers State University of New Jersey and a doctorate degree from Ernest Mario School of Pharmacy.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.08.2026 | 3’250’000 ( 3.31% ) | 370 500 $ | 30.09.2026 | |
| 16.06.2026 | 64’178 ( 0.08% ) | 152 423 $ | 30.09.2026 |
Aktive Positionen von Sireesh Appajosyula
| Unternehmen | Position | Beginn |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 09.10.2026 |
Highpoint Pharmaceuticals LLC | Corporate Officer/Principal | 01.01.2018 |
Channel Bioconsulting LLC | Corporate Officer/Principal | 01.01.2015 |
Ehemalige bekannte Positionen von Sireesh Appajosyula
| Unternehmen | Position | Ende |
|---|---|---|
| CANTON STRATEGIC HOLDINGS, INC. | Vorstandsvorsitzender | - |
| 9 METERS BIOPHARMA, INC. | Geschäftsführer | 17.07.2023 |
Salix Pharmaceuticals, Inc.
 Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Sireesh Appajosyula
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Salix Pharmaceuticals, Inc.
Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernest Mario School of Pharmacy
 Ernest Mario School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Tharimmune, Inc.
 Tharimmune, Inc. Data Processing ServicesTechnology Services Engages in institutional blockchain infrastructure and digital asset treasury management and clinical stage bio-technology services | Technology Services |
Highpoint Pharmaceuticals LLC | |
Channel Bioconsulting LLC |
